Literature DB >> 8470021

[Detection of antibodies against Trypanosoma cruzi in blood donors].

A A Ramos-Echevarria1, V M Monteón-Padilla, P A Reyes-López.   

Abstract

American trypanosomiasis is an endemic disease in Mexico. Blood transfusion has been recognized as the second main mechanism of transmission in South American countries. There is no definitive information available for Mexico. We obtained the prevalence of IgG antibodies against Trypanosoma cruzi among 1076 blood donors at the Instituto Nacional de Cardiología "Ignacio Chávez" in Mexico City. We used an antigen freshly prepared from local isolates, and the complete and soluble antigen preparations were analyzed with the Western blot technique using sera previously characterized as reactive. Blood donors' antibodies were studied with DOT-ELISA and Western blot. All donors were asked in regard to place of birth, and blood samples were serologically tested as usual in transfusion practice. The presence of IgG antibodies to T. cruzi, confirmed with a high-specificity test, showed a prevalence of 0.28 per cent. Screening for antibodies to T. cruzi; should be included in the evaluation of blood donors in Mexico.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8470021

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  3 in total

1.  Serodiagnosis of American trypanosomosis by using nonpathogenic trypanosomatid antigen.

Authors:  V M Monteón; L Guzmán-Rojas; C Negrete-García; J L Rosales-Encina; P A Lopez
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

2.  Molecular diagnosis of Chagas' disease and use of an animal model to study parasite tropism.

Authors:  J M Vera-Cruz; E Magallón-Gastelum; G Grijalva; A R Rincón; C Ramos-García; J Armendáriz-Borunda
Journal:  Parasitol Res       Date:  2003-01-16       Impact factor: 2.289

Review 3.  ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.

Authors:  Pedro E A A Brasil; Liane De Castro; Alejandro M Hasslocher-Moreno; Luiz H C Sangenis; José U Braga
Journal:  BMC Infect Dis       Date:  2010-11-25       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.